PatientsVille.com Logo

ANAEMIA POSTOPERATIVE and FOSAMAX

PatientsVille

ANAEMIA POSTOPERATIVE Symptoms and Causes

We are sorry, but no medical information on this topic currently exists in our database. Our articles are updated often, please revisit soon.

Check out the latest treatments for ANAEMIA POSTOPERATIVE

➢ ANAEMIA POSTOPERATIVE treatment research studies

➢ FOSAMAX clinical trials, surveys and public health registries

Find Drug Side Effect reports



FOSAMAX Side Effects

Femur Fracture (5674)
Anxiety (3177)
Osteonecrosis (2820)
Fall (2638)
Depression (2384)
Arthralgia (1887)
Dental Caries (1636)
Arthropathy (1621)
Back Pain (1566)
Low Turnover Osteopathy (1355)
Anaemia (1283)
Osteomyelitis (1270)
Hypertension (1242)
Blood Cholesterol Increased (1236)
Impaired Healing (1123)
Abscess (1121)
Adverse Event (1103)
Bone Density Decreased (1051)
Bone Disorder (1050)
Chest Pain (1022)
Bronchitis (915)
Tooth Disorder (890)
Arthritis (849)
Gastrooesophageal Reflux Disease (838)
Intramedullary Rod Insertion (835)
Osteonecrosis Of Jaw (834)
Cataract (805)
Osteoarthritis (784)
Osteoporosis (749)
Pain In Extremity (719)
Stress Fracture (715)
Jaw Disorder (708)
Asthma (706)
Cellulitis (697)
Chronic Obstructive Pulmonary Disease (679)
Abdominal Pain (632)
Diarrhoea (584)
Asthenia (582)
Constipation (557)
Bursitis (552)
Atrial Fibrillation (550)
Pain (544)
Exostosis (531)
Fatigue (522)
Oral Infection (505)
Carpal Tunnel Syndrome (503)
Dizziness (502)
Foot Fracture (501)
Hip Fracture (497)
Headache (477)

➢ More

Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

After being on Fosamax for approximately four and one half years suddenly I developed severe medial bilateral knee pain. Have pain when walking down and up stairs. I have NO history of arthritis, no inflammation or redness at the location of pain. I

Can Fosamax cause a drop in blood pressure? Can it worsen pre-existing anaemia. I've taken 4 weekly 70mg tablets and am feeling dizzy and week with loss of sensation in my fingers and joint pains. As I have suffered a year ago from kidney failure

Critical hypertension

Does fosamax affect on teeth cause a major concern. I need it for my bones,but want to keep my teeth!

I feel swollen and feel fatter since starting Fosamax.Weight gain is maybe three lbs but eyes are puffy and face seems swollen. I plan to see my doctor this week. I don't want my osteoporosist to get worse so will most likely stay on it but a diureti

I have been using fosamax for years for osteopenia. I have good teeth with1 root canal. I am wooried about it affecting my teeth. Is taking it a major risk for teeth? Is there a better way to prevent bone loss? I am 64, good health and use weight tra

I have had gastric bypas and would like to know if I can take Fosamax.

I started generic fosamax 10 days ago . After my first dose( sunday)I was fine, but the day after (Monday) in the afternoon I experienced crushing pain in my upper spine that radiated to the front. I had severe difficulty rising f

I took Actonel for 2 months and the psorasis in my scalp got out of control. My Doctor could find no connection. I have been on Fosamax for one month now and the same thing is happening. Have there been other reports of this side effect?

I've heard that it's worse for the bones in the head (teeth, jaw bones, etc.) than anywhere in the body). I'm sure there are exceptions and people who get along fine, but there are WAY too many cases to chance it!

Been overdosed over nine months on 5700mg of Diaformin per dayby my GP. Had lost weight, loss of appetite anaemia B12 deficiency vitamin D deficiency lethagy pains in back on exertion etc. Rushed to hospital, no recordable blood sugar, acut

Can Fosamax cause a drop in blood pressure? Can it worsen pre-existing anaemia. I've taken 4 weekly 70mg tablets and am feeling dizzy and week with loss of sensation in my fingers and joint pains. As I have suffered a year ago from kidney failure

Had reclast infusion in Jan 2010, diagnosed with Anaemia August this year. What is the best treatment and how long will this symptom last. No other problems as yet.

I am anaemic and i've been treating my acne with doxycycline but instead my anaemia got worse i'm drowzy,my head feels heavy and i have a headache from hell.

My college have ca pancreatis - cum metastases in liver. After inject. of gemcitabin she got severe toxic anaemia. Do she must get transfusion or eritropoetin drug?

Pains in arms legs and shoulders terrible indigestion nausea fatigue anaemia anxiety sleepiness hot flushes high blood presure tingling in the limbs feeling very ill.prescribed steroids

Physician from VENEZUELA reported Combaren side effect on May 12, 2006. Male patient, 73 years of age, was diagnosed with procedural pain, postoperative care and was treated with Combaren. After drug was administered, patient experienced the followin

ANAEMIA POSTOPERATIVE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults
Condition: Healthy Volunteers
Interventions: Drug: Alendronate;   Drug: Hepatitis B Vaccine;   Drug: Placebo
Outcome Measures: Safety/Adverse events;   Efficacy
2 Recruiting Testosterone and Alendronate in Hypogonadal Men
Conditions: Hypogonadism;   Osteopenia;   Osteoporosis
Interventions: Drug: Testosterone;   Drug: Alendronate;   Drug: Placebo Alendronate;   Drug: Placebo Testosterone
Outcome Measure: Spine Bone Mineral Density by DXA
3 Unknown † Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Condition: Peritoneal Dialysis
Intervention: Drug: alendronate (Fosamax)
Outcome Measures: 1.Changes of calcification score of coronary arteries and aorta;   2.Changes of bone density;   changes of parathyroid hormone;   changes of serum calcium and phosphate level;   changes of C reactive protein;   changes of lipid profile;   adverse reactions
4 Unknown † Fosamax for Childhood Cancer Survivors
Condition: Osteoporosis
Interventions: Drug: Alendronate;   Drug: Placebo
Outcome Measures: The percent change in bone mineral density (BMD) at lumbar spine at 36-weeks in subjects who receive active and control treatments;   Changes in BMD at femoral neck;   Changes in biochemical markers of bone turnover;   Occurrence of clinical bone-related symptoms at 12-weeks and end of this study
5 Not yet recruiting RA Denosumab on Bone Microstructure Study
Condition: Rheumatoid Arthritis
Interventions: Drug: Denosumab;   Drug: Alendronate
Outcome Measures: Changes from baseline in bone volumetric density at distal radius at 6th month;   Changes from baseline in trabecular bone microarchitecture at distal radius at 6th month;   Changes from baseline in bone volumetric density at the 2nd metacarpal bone at 6th month;   Changes from baseline in trabecular bone microarchitecture at 2nd metacarpal bone at 6th month;   Changes from baseline in areal bone density at total hip at 6th month;   Changes from baseline in areal bone density at lumbar spine at 6th month;   Changes in areal bone density at distal radius at 6th month;   Changes from baseline in bone volumetric density at distal radius at 3rd month;   Changes from baseline in trabecular bone microarchitecture at distal radius at 3rd month;   Changes from baseline in bone volumetric density at the 2nd metacarpal bone at 3rd month;   Changes from baseline in trabecular bone microarchitecture at 2nd metacarpal bone at 3rd month;   Changes from baseline in areal bone density at total hip at 3rd month;   Changes from baseline in areal bone density at lumbar spine at 3rd month;   Changes in areal bone density at distal radius at 3rd month
6 Recruiting Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis
Condition: Postmenopausal Women With Osteoporosis
Interventions: Drug: Romosozumab;   Drug: Alendronate
Outcome Measures: Incidence of clinical fracture;   Incidence of new vertebral fracture;   Incidence of fracture;   Percent changes in DXA Bone Mineral Density from baseline to 12 months;   Percent changes in DXA Bone Mineral Density from baseline to 24 months;   Percent changes in DXA Bone Mineral Density from baseline to 36 months
7 Not yet recruiting Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial
Condition: HIV
Intervention: Drug: alendronate/vitamin D
Outcome Measures: Percentage changes in BMD at a) the lumbar spine and b) proximal femur;   Feasibility;   Acceptability;   Safety/Tolerability;   Adherence;   Bone Biomarkers
8 Not yet recruiting Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
Condition: Calcific Aortic Stenosis
Interventions: Drug: Denosumab;   Drug: Alendronic Acid;   Drug: Denosumab Placebo;   Drug: Alendronic Acid Placebo
Outcome Measures: Change in aortic valve calcium score;   Change in aortic valve 18F-NaF uptake;   Change in aortic-jet velocity;   Change in thoracic aortic and coronary artery calcium score;   Change in thoracic spine bone mineral density;   Change in quality of life determined by Short Form 36 Questionnaire
9 Recruiting Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
Condition: Osteoporosis
Interventions: Drug: Alendronate;   Drug: Placebo
Outcome Measures: Incidence of new osteoporotic fractures;   Equivalence of deaths with and without continued bisphosphonate therapy;   Incidence of the combination of fractures and deaths
10 Recruiting Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly
Condition: Alveolar Bone Healing After Dental Extraction
Intervention: Procedure: Dental extraction
Outcome Measures: Alveolar socket filled by new bone;   Mucosal injury
11 Unknown † The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
Condition: Osteoporosis
Intervention: Drug: Alendronate
Outcome Measure:
12 Unknown † Osteoporosis and Dental Implant
Condition: Osteoporosis
Interventions: Drug: alendronate once weekly 70mg;   Drug: placebo
Outcome Measure: Dental CT
13 Unknown † Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
Conditions: Osteoporosis;   Cystic Fibrosis
Interventions: Drug: alendronate sodium;   Drug: calcium carbonate;   Drug: cholecalciferol
Outcome Measure:
14 Unknown † Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease
Conditions: Gaucher's Disease;   Osteopenia
Interventions: Drug: alendronate sodium;   Drug: calcium carbonate;   Drug: cholecalciferol
Outcome Measure:
15 Unknown † Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women
Condition: Osteoporosis
Intervention: Drug: Maxmarvil®
Outcome Measure: analysis of Alendronate concentrate
16 Recruiting Stem Cell Recruitment in Osteoporosis Therapy
Condition: Low Bone Density
Interventions: Drug: Teriparatide;   Drug: Alendronate;   Dietary Supplement: calcium and vitamin D
Outcome Measures: Number of Stro-1+ MSCs at bone resorption sites in bone biopsies of subjects treated with PTH or ALN.;   Number of p-Smad 2/3+ cells/mm2 at active resorption sites on bone biopsy specimens of subjects treated with PTH or ALN.;   The percent increase in Stro-1+/CD146+ cells in the blood before and after treatment with PTH or ALN.;   Number of human Stro-1+ MSCs at bone resorption sites in bone of Rag2-/- mice reconstituted with human bone marrow derived from subjects treated with PTH or ALN.
17 Recruiting Twenty Four Month Extension Study of BA058-05-003
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Alendronate
Outcome Measures: Safety;   Vertebral Fracture Incidence;   Non-vertebral Fracture Incidence
18 Recruiting Bisphosphonate Biomarker Study
Conditions: Osteoporosis, With or Without Treatment;   Bisphosphonate Treatment;   Atypical Femur Fracture;   Bisphosphonate Related Osteonecrosis of the Jaws (BRONJ);   Healthy Volunteers
Intervention:
Outcome Measures: Absorption, Distribution, Metabolism, Excretion (ADME) Profiling of DNA from all sample types vs. normative data for the ADME panel and across study groups;   Differential expression of miRNA biomarkers across participant groups within the study
19 Recruiting Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study
Condition: Osteoporosis
Intervention: Drug: Alendronate
Outcome Measures: Clinical site recruitment rate;   Participant recruitment rate;   Contracting and procedures;   Administrative procedures;   Osteonecrosis of the jaw;   Atypical femoral fracture;   Clinical fracture rate
20 Recruiting Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
Condition: Postmenopausal Osteoporosis
Intervention: Drug: Teriparatide 40-mcg subcutaneous injection
Outcome Measure: Bone turnover marker (blood sample)